LOLI take that back re ASX being gutless at least with regard to CHM. Look what just popped up on CHM announcementshttp://imagesignal.comsec.com.au/asxdata/20081204/pdf/00910734.pdf
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%